Covered recipient · General Payments record
JAMES BASS
Allopathic & Osteopathic Physicians Pediatrics Neonatal-Perinatal Medicine
General Payments · PY2021–2024
$1,063.80
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $598.87 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $518.97 | 16 |
| REVANCE THERAPEUTICS, INC. | $79.90 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.51 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288593 | CMS |
| ABBVIE INC. | $6.19 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288595 | CMS |
| ABBVIE INC. | $19.56 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288597 | CMS |
| ABBVIE INC. | $5.38 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288599 | CMS |
| ABBVIE INC. | $63.49 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288601 | CMS |
| ABBVIE INC. | $22.54 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288603 | CMS |
| ABBVIE INC. | $20.69 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288605 | CMS |
| ABBVIE INC. | $18.80 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288607 | CMS |
| ABBVIE INC. | $23.70 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288609 | CMS |
| ABBVIE INC. | $66.38 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288611 | CMS |
| ABBVIE INC. | $57.81 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288613 | CMS |
| ABBVIE INC. | $52.83 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288615 | CMS |
| ABBVIE INC. | $24.38 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288617 | CMS |
| ABBVIE INC. | $4.94 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288619 | CMS |
| ABBVIE INC. | $100.61 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288621 | CMS |
| ABBVIE INC. | $19.16 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103288623 | CMS |
| REVANCE THERAPEUTICS, INC. | $16.66 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147912410 | CMS |
| REVANCE THERAPEUTICS, INC. | $26.61 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147912412 | CMS |
| REVANCE THERAPEUTICS, INC. | $14.33 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147912414 | CMS |
| REVANCE THERAPEUTICS, INC. | $22.30 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147912416 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.